BLISSGVS

Bliss GVS Pharma

₹114.07
-1.92 (-1.66%)
16 July, 2024 16:02 BSE: 506197 NSE: BLISSGVS ISIN: INE416D01022

Start SIP in Bliss GVS Pharma

Start SIP

Bliss GVS Pharma Performance

Day Range

  • Low 114
  • High 117
₹ 114

52 Week Range

  • Low 77
  • High 150
₹ 114
  • Open Price117
  • Previous Close116
  • Volume258211

Bliss GVS Pharma Share Price

  • Over 1 Month + 7.75%
  • Over 3 Month + 3.4%
  • Over 6 Month -13.57%
  • Over 1 Year + 25.95%

Bliss GVS Pharma Key Statistics

P/E Ratio 15.9
PEG Ratio 2.4
Market Cap Cr
Price to Book Ratio 1.2
EPS 7.3
Dividend 0
Relative Strength Index 65.98
Money Flow Index 76.39
MACD Signal 1.12
Average True Range 4.46
Bliss GVS Pharma Financials
IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 164161171109143
Operating Expenses Qtr Cr 13913312998133
Operating Profit Qtr Cr 2529421111
Depreciation Qtr Cr 66654
Interest Qtr Cr 22115
Tax Qtr Cr -481232
Net Profit Qtr Cr -11213476
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 639649
Operating Expenses Annual Cr 498508
Operating Profit Annual in Cr 10790
Depreciation Cr 2415
Interest Annual Cr 610
Tax Annual Cr 2030
Net Profit Annual Cr 5185
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 12644
Cash from Investing Activity Annual Cr -110-13
Cash from Financing Annual Activity Cr -21-26
Net Cash Flow Annual Cr -45
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 988937
Fixed Assets Annual Cr 338328
Total Non Current Assets Annual Cr 380410
Total Current Assets Annual Cr 773730
Total Assets Annual Cr 1,1531,140
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 9490
ROE Annual % 59
ROCE Annual % 1113
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2324
IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 198201212160185
Operating Expenses Qtr Cr 170157158135179
Operating Profit Qtr Cr 284454246
Depreciation Qtr Cr 77665
Interest Qtr Cr 22115
Tax Qtr Cr 111167-4
Net Profit Qtr Cr -92842153
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 799769
Operating Expenses Annual Cr 620634
Operating Profit Annual in Cr 151117
Depreciation Cr 2619
Interest Annual Cr 710
Tax Annual Cr 3529
Net Profit Annual Cr 7571
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 15234
Cash from Investing Activity Annual Cr -133-8
Cash from Financing Annual Activity Cr -21-25
Net Cash Flow Annual Cr -12
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 967884
Fixed Assets Annual Cr 370374
Total Non Current Assets Annual Cr 402459
Total Current Assets Annual Cr 812697
Total Assets Annual Cr 1,2141,157
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 9688
ROE Annual % 88
ROCE Annual % 1512
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2318

Bliss GVS Pharma Technicals

EMA & SMA

Current Price
₹114.07
-1.92 (-1.66%)
pointer
  • Bullish Moving Average
  • ___
  • 14
  • Bearish Moving Average
  • ___
  • 2
  • 20 Day
  • ₹109.23
  • 50 Day
  • ₹108.74
  • 100 Day
  • ₹110.58
  • 200 Day
  • ₹109.02
  • 20 Day
  • ₹107.18
  • 50 Day
  • ₹106.90
  • 100 Day
  • ₹112.40
  • 200 Day
  • ₹113.95

Bliss GVS Pharma Resistance and Support

PIVOT
₹116.78
Resistance
First Resistance 118.54
Second Resistance 121.08
Third Resistance 122.85
RSI 65.98
MFI 76.39
MACD Single Line 1.12
MACD 2.47
Support
First Support 114.23
Second Support 112.46
Third Supoort 109.92

Bliss GVS Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 776,393 32,515,339 41.88
Week 1,367,322 78,333,854 57.29
1 Month 771,958 38,088,395 49.34
6 Month 651,677 29,345,018 45.03

Bliss GVS Pharma Result Highlights

Bliss GVS Pharma Synopsis

NSE-Medical-Generic Drugs

Bliss Gvs Pharma is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 605.46 Cr. and Equity Capital is Rs. 10.47 Cr. for the Year ended 31/03/2024. Bliss GVS Pharma Ltd. is a Public Limited Listed company incorporated on 11/12/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1984PLC034771 and registration number is 034771.
Market Cap 1,218
Sales 605
Shares in Float 6.82
No of funds 25
Yield 0.43
Book Value 1.23
U/D Vol ratio 1
LTDebt / Equity 4
Alpha -0.05
Beta 1.17

Bliss GVS Pharma Shareholding Pattern

Owner NameMar-24Dec-23Sep-23
Promoters 34.97%34.97%35.06%
Mutual Funds
Insurance Companies 6.59%6.59%6.61%
Foreign Portfolio Investors 14.74%15.35%16.31%
Individual Investors 31.71%30.78%29.17%
Others 11.99%12.31%12.85%

Bliss GVS Pharma Management

Name Designation
Mr. S R Vaidya Chairman & Ind.Director
Mr. Gagan Harsh Sharma Managing Director
Dr. Vibha Gagan Sharma Whole Time Director
Mrs. Shruti Vishal Rao Whole Time Director
Mr. Santosh L Parab Independent Director
Ms. Shilpa Bhatia Independent Woman Director

Bliss GVS Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Bliss GVS Pharma Corporate Action

Date Purpose Remarks
2024-05-02 Audited Results & Final Dividend
2024-01-23 Quarterly Results
2023-11-01 Quarterly Results
2023-08-01 Quarterly Results
2023-05-11 Audited Results & Final Dividend

Bliss GVS Pharma MF Shareholding

Name Amount(cr)

Bliss GVS Pharma FAQs

What is Share Price of Bliss GVS Pharma ?

Bliss GVS Pharma share price is ₹114 As on 16 July, 2024 | 15:48

What is the Market Cap of Bliss GVS Pharma ?

The Market Cap of Bliss GVS Pharma is ₹1197.3 Cr As on 16 July, 2024 | 15:48

What is the P/E ratio of Bliss GVS Pharma ?

The P/E ratio of Bliss GVS Pharma is 15.9 As on 16 July, 2024 | 15:48

What is the PB ratio of Bliss GVS Pharma ?

The PB ratio of Bliss GVS Pharma is 1.2 As on 16 July, 2024 | 15:48

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91